Stockscreener 앱 받기
8.47
0.59%
-0.05
시간 외 거래:
8.42
-0.05
-0.59%
전일 마감가:
$8.52
열려 있는:
$8.58
하루 거래량:
1.80M
Relative Volume:
0.55
시가총액:
$1.78B
수익:
$557.51M
순이익/손실:
$-35.71M
주가수익비율:
-47.06
EPS:
-0.18
순현금흐름:
$15.50M
1주 성능:
+1.07%
1개월 성능:
+2.54%
6개월 성능:
-1.63%
1년 성능:
-0.94%
1일 변동 폭
$8.40
$8.61
1주일 범위
$8.27
$8.675
52주 변동 폭
$6.015
$11.31
바이오크리스트 Stock (BCRX) Company Profile
명칭
Biocryst Pharmaceuticals Inc
전화
919-859-1302
주소
4505 EMPEROR BOULEVARD, DURHAM, NC
BCRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCRX
Biocryst Pharmaceuticals Inc
|
8.47 | 1.79B | 557.51M | -35.71M | 15.50M | -0.18 |
|
ZTS
Zoetis Inc
|
154.79 | 68.86B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.97 | 46.93B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.04 | 20.71B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
307.24 | 13.81B | 2.99B | 1.21B | 1.13B | 25.06 |
바이오크리스트 Stock (BCRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-02-25 | 개시 | Wedbush | Outperform |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-09-18 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-08-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-02-22 | 업그레이드 | Needham | Hold → Buy |
| 2022-11-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-05 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-04-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-04-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-10 | 개시 | Oppenheimer | Outperform |
| 2021-08-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-08-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-01 | 개시 | Cowen | Outperform |
| 2020-09-29 | 재개 | JP Morgan | Overweight |
| 2020-06-17 | 개시 | BTIG Research | Neutral |
| 2020-05-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-11-15 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-05-24 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-11-16 | 재개 | Piper Jaffray | Overweight |
| 2018-08-08 | 재개 | JP Morgan | Overweight |
| 2018-07-17 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2018-06-22 | 개시 | Seaport Global Securities | Neutral |
| 2018-01-02 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-12-20 | 개시 | Barclays | Equal Weight |
| 2017-09-15 | 개시 | RBC Capital Mkts | Sector Perform |
| 2017-09-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-09-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2017-02-16 | 개시 | Ladenburg Thalmann | Buy |
| 2016-08-12 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2016-08-04 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | 재확인 | FBR Capital | Outperform |
| 2016-02-09 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-02-09 | 다운그레이드 | Needham | Buy → Hold |
모두보기
바이오크리스트 주식(BCRX)의 최신 뉴스
BioCryst Pharmaceuticals Inc. stock prediction for this weekGold Moves & AI Forecast for Swing Trade Picks - Newser
How to track smart money flows in BioCryst Pharmaceuticals Inc.Risk Management & High Conviction Trade Alerts - Newser
Custom watchlist performance reports with BioCryst Pharmaceuticals Inc.July 2025 Update & AI Forecasted Entry/Exit Points - Newser
Leading vs lagging indicators on BioCryst Pharmaceuticals Inc. performanceQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
How to integrate BioCryst Pharmaceuticals Inc. into portfolio analysis tools2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Will BioCryst Pharmaceuticals Inc. see short term momentum2025 EndofYear Setup & Safe Swing Trade Setups - Newser
Is a relief rally coming for BioCryst Pharmaceuticals Inc. holdersJuly 2025 Rallies & Verified Momentum Stock Ideas - Newser
Can technical indicators confirm BioCryst Pharmaceuticals Inc.’s reversalTrade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Understanding BioCryst Pharmaceuticals Inc.’s price movementShort Setup & Daily Oversold Stock Bounce Ideas - Newser
What to do if you’re stuck in BioCryst Pharmaceuticals Inc.Market Growth Report & Fast Gain Stock Tips - Newser
Applying Elliott Wave Theory to BioCryst Pharmaceuticals Inc.Market Movers & Fast Gain Swing Trade Alerts - Newser
Using fundamentals and technicals on BioCryst Pharmaceuticals Inc.2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Is BioCryst Pharmaceuticals Inc. a candidate for recovery playQuarterly Performance Summary & Fast Moving Market Watchlists - Newser
Real time pattern detection on BioCryst Pharmaceuticals Inc. stockJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
What MACD and RSI say about BioCryst Pharmaceuticals Inc.Weekly Gains Summary & Stepwise Trade Signal Implementation - Newser
Sentiment analysis tools applied to BioCryst Pharmaceuticals Inc.2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - Newser
How to read the order book for BioCryst Pharmaceuticals Inc.Weekly Loss Report & Consistent Return Strategy Ideas - Newser
Published on: 2025-08-27 20:06:29 - Newser
Is BioCryst Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser
Published on: 2025-08-27 11:33:19 - Newser
What momentum shifts mean for BioCryst Pharmaceuticals Inc.Weekly Trade Review & Accurate Intraday Trade Tips - Newser
Can you recover from losses in BioCryst Pharmaceuticals Inc.2025 Performance Recap & Consistent Income Trade Ideas - Newser
Will breakout in BioCryst Pharmaceuticals Inc. lead to full recoveryWeekly Earnings Recap & Real-Time Chart Breakout Alerts - Newser
Automated trading signals detected on BioCryst Pharmaceuticals Inc. - Newser
Chart based exit strategy for BioCryst Pharmaceuticals Inc.Market Performance Summary & Advanced Technical Signal Analysis - Newser
Is It Too Late to Sell BioCryst Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Will BioCryst Pharmaceuticals Inc. stock benefit from AI tech trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser
바이오크리스트 (BCRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
0.59%
자본화:
|
볼륨(24시간):